Team - AiM Medical Robotics

Leadership Team

Gregory Fischer, PhD

CEO/President, Founder & Co-inventor

Dr. Gregory Fischer has spent his career developing innovative technologies for image-guided surgical interventions. He is a pioneer in MRI-compatible surgical robotics capable of utilizing real-time images from inside the body to guide precision robot-assisted interventions. Dr. Fischer is a Founder of AiM Medical Robotics, a company leveraging technology from his team's research to revolutionize the neurosurgery experience. Dr. Fischer has been a Professor of Robotics Engineering at Worcester Polytechnic Institute (WPI) and PI of the Automation and Interventional Medicine Robotics Research Laboratory where his research has focused on medical robotics, specifically the use of real-time feedback to guide surgical procedures. He was the Founder of the PracticePoint Medtech R&D Center for Healthcare Cyber-physical Systems, an MA state-supported Medtech accelerator with advanced point-of-practice clinical testing facilities including an OR and 3T MRI suite dedicated to research and product development. Dr. Fischer is also a Senior Member of the National Academy of Inventors.

Dr. Fischer holds a PhD in Mechanical Engineering, an MSE in both Mechanical Engineering and Electrical Engineering from Johns Hopkins University, and a BS in both Mechanical Engineering and Electrical Engineering from Rensselaer Polytechnic Institute.

https://www.linkedin.com/in/gregfischer/

Bob Cathcart

EXECUTIVE CHAIRMAN

Bob is an experienced Medical Device executive, with over 30 years in the industry. His extensive General Management experience includes serving as CEO of Clear Guide Medical, an image-guided surgical company, and as Senior Vice President of Global Sales for Hansen Medical, the leader in Surgical Robotics for Cardiovascular. Bob was part of the senior executive team that led the sale of Hansen Medical to Auris Robotics, which was then acquired by J&J in 2019. Prior to Hansen Medical, Bob was President of Datascope Cardiac Assist, a world leader in cardiac support devices. Bob holds a BA in Business from DePauw University.

Jonathan Sackier, MB, ChB, FRCS, FACS, DSC

Chief Medical Officer, Board Member

Dr. Jonathan Sackier is a physician entrepreneur with a diverse background including clinical practice, academic work, and education. He is the current Chief Medical Officer of Helios Medical Technologies, a medical technology company offering a revolutionary, non-invasive device for neuro. He was also a Founding Partner and Director of Computer Motion, which built the world’s first surgical robot (AESOP) which then eventually merged into Intuitive Surgical to become the largest surgical robotics company in the world. Dr. Sackier has also served as a Visiting Professor at Oxford University and as a Professor at George Washington University.

Dr. Sackier holds an Mb,ChB, Medicine from Liverpool University and completed fellowships with both the Royal College of Surgeons and the American College of Surgeons.

Julie G. Pilitsis, MD, PhD, MBA

Chief Clinical Advisor, Founder & Co-inventor

Neurosurgeon, Dean of Florida Atlantic University, Charles E. Schmidt College of Medicine, and President of North American Neuromodulation Society (NANS)

Greg Cole, PhD

SCIENCE & TECHNOLOGY ADVISOR, Co-inventor

Dr. Greg Cole, Ph.D. is a research scientist with expertise in robotics, engineering, and medical device development. He previously served as both Director of New Robot Products and Director of Advanced Development at Seegrid, an autonomous industrial vehicle corporation. As a graduate student, Dr. Cole collaborated with Dr. Gregory Fischer on research in interventional robotics and co-founded Medical Motion Corporation to enable the development of robotic surgical technologies by other universities. He has since held engineering and leadership roles at Philips Corporate Research, where he contributed to the development of the Fiber Optic Real Shape system (FORS) and other novel image-guided interventional systems, and ABB Corporate Research, where he led increasingly impactful programs including ABB's electric vehicle charging group's ACD systems, IP development in ABB Corporate Research US, as well as startup engagement management for ABBs venture capital division.

Dr. Cole holds a Ph.D. in Robotics Engineering from Worcester Polytechnic Institute.

Clinical Advisors

Robert Gross, MD, PhD

Chairman, Department of Neurosurgery, Emory University

Chair & Professor of Department of Neurosurgery
Emory University School of Medicine

Andre Machado, MD, PhD

Chairman of the Neurological Institute, Chair in functional Neurosurgery, Professor of Neurosurgery Cleveland Clinic College of Medicine

Chairman of the Neurological Institute | Chair in Functional Neurosurgery | Professor of Neurosurgery
Cleveland Clinic College of Medicine

Jon T. Willie, MD, PhD

Director of Stereotactic and Epilepsy Surgery, Department of Neurosurgery, Washington University, St. Louis

Director of Stereotactic, Functional, and Epilepsy Neurosurgery | Associate Professor of Neurosurgery, Biomedical Engineering, Psychiatry, Neuroscience and Neurology
Washington University School of Medicine

Joshua M Rosenow, MD

Director of Functional Neurosurgery, Northwestern University Memorial Hospital

Director of Functional Neurosurgery and Epilepsy Surgery | Professor of Neurosurgery, Neurology and Physical Medicine and Rehabilitation
Northwestern University Feinberg School of Medicine & Northwestern Memorial Hospital

Business Advisors

Yulun Wang, PhD

Corporate Advisor, Founder and Chairman Computer Motion. Founder and Chairman InTouch Health

Samantha Surrey

Board Member, Founder of Surrey Capital Partners

Samantha Surrey is as a life science investor, entrepreneur, and scientist with a distinguished track record. She is the founder of Surrey Capital Partners, a life science impact innovation fund focused on the life sciences industry. Over the last decade, since leaving her corporate role at GSK, Samantha has been the Co-Founder and Managing Partner of Decision Medical Ventures and currently sits on the board of directors of Decision Sciences Medical Company.

She holds an M.S. Eng. in Biomedical Engineering from the University of Pennsylvania and an undergraduate degree in Engineering and Applied Mathematics from Cornell University.

Scott Davis, PhD

Board Observer, Senior Associate, Life Sciences at Sontag Innovation Fund

David Noonan, PhD

Corporate Advisor, Chief Technology Ofﬁcer at Moon Surgical, Senior Director R+D at Auris Health

Alex Wilson

Board Observer, Principal at IQ Capital

Dr. Alex Wilson is a Principal at IQ Capital, a deep-tech venture capital fund in the UK. Alex is a Director at several companies working at the bleeding-edge of scientific innovation, from developing novel cancer diagnostics to reducing global carbon emissions. Prior to IQ Capital, Alex worked as an Analyst at a Private Equity fund. He holds a PhD in computational biology, with published research in a wide range of disciplines, including fundamental quantum mechanics, biotechnology, and machine learning.